阅读说明：本技术 联合奋抗针剂 (Combined injection ) 是由 李文化 于 2021-07-03 设计创作，主要内容包括：联合奋抗针剂是为治疗类风湿关节炎,根据病因病理、药理及联合用药原则,优选应用具有抑制溶血性链球菌有效成分的中草药中各原药之间相生、相须、相同亲和力的抑制作用与抗毒、抗炎、抗过敏、杀菌西药恰当联合的协同奋抗作用。中西结合,科学应用,增强药力,扩大抗菌谱,有效抑制杀灭溶血性链球菌等病原菌。本发明经五年对160位患者临床应用,类风湿性关节治愈率95％复发率仅占5％。同时服用六科追风丸,打针服药期间,注重修养无一例复发。本发明是对常规治疗类风湿性关节炎的重大突破,是联合用药最新发明,为扩大抗菌谱做出重大贡献。(The combined injection is used for treating rheumatoid arthritis, and preferably applies the inhibiting effect of inhibiting the mutual growth, mutual reinforcement and same affinity among all raw medicines in the Chinese herbal medicine with the hemolytic streptococcus effective component and the synergistic injection effect of properly combining the western medicines of resisting toxicity, resisting inflammation, resisting allergy and sterilizing according to the etiology, pathology, pharmacology and combined medication principle. The traditional Chinese medicine and the western medicine are combined and scientifically applied, so that the efficacy of the medicine is enhanced, the antibacterial spectrum is expanded, and pathogenic bacteria such as hemolytic streptococcus and the like are effectively inhibited and killed. The invention is clinically applied to 160 patients for five years, and the rheumatoid joint cure rate is 95 percent, and the recurrence rate is only 5 percent. The pill can be administered simultaneously, and during injection and administration, there is no recurrence. The invention is a breakthrough of the conventional treatment of rheumatoid arthritis, is the latest invention of combined medication, and makes a great contribution to the expansion of antibacterial spectrum.)